Assay

Financial-condition grades for SEC filers

Company Report · as of Oct 9, 2026


HomeCompaniesSectorsCalendarLast night

Anteris Technologies Global Corp.AVR · healthcare
GradeNonecomputable_factors_below_threshold: 5 of 14 inputs computable; 7 are required
Reliability0.83 AUCfailure model, filers with $12.5M to $120M assets; 95% interval 0.79 to 0.86; 201 events, 2020 to 2025
Peer failure rate1.07% a yearItem 1.03 bankruptcies, same asset band, 2012 to 2025
Size band$12.5M to $120M assetstotal assets $23.0M[1]
Standard universeinsiderevenue above $1M and assets above $10M[1-2]
Warningsdilution, thin datanot computable: fortress balance sheet
Inputs computable5 of 14
Graded fromfilings received through Feb 26, 2026225 days before the rescan; every figure keyed to the SEC receipt date
Last close$6.632026-10-08; market equity $646.1M; iex feed
Price used in gradeNone
Share price, twelve months to the rescansplit-adjusted close; a lollipop at every rescan carries the letter held then; baseline ticks are SEC receipt dates of the inputs; ranges and dragging scroll the full history
$5$10NovDecJanFebMarAprMayJunJulAugSepOct$6.63
ABCDE20132014201520162017201820192020202120222023202420252026

Percentile at every rescan on file, Jan 21, 2012 to Oct 9, 2026; stronger toward the top. Hover for the date.

Open this report as it stood on

Letter setLetterPercentileBand
Jan 21, 2012nonen/a
Mar 21, 2026nonen/aQ2

Each date opens the report as it stood on that rescan.

Business, in the company's words. Opening of Item 1 of the 10-K received Feb 26, 2026; the document on sec.gov.

Anteris is a structural heart company dedicated to revolutionizing cardiac care by pioneering science-driven and measurable advancements to restore heart valve patients to healthy function. Our lead product, the DurAVR® THV System, was designed in collaboration with the world’s leading interventional cardiologists and cardiac surgeons to treat aortic stenosis — a potentially life-threatening condition resulting from a narrowing of the aortic valve. The balloon-expandable DurAVR® THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow.

Warnings [top]

Dilution. split-adjusted year-over-year share growth is 169.6%[3-4]
Thin data. 5 of 14 grade factors are computable; minimum is 7

7 checks ran; none of them enters the letter. The checks are listed on the warnings screen.

The Fourteen Inputs [top]

Lower percentile is stronger. Source numbers open the SEC filing; a range that spans filings opens the sources table.

InputPercentile, 0 to 100ValueSourcePeer medianPercentilePeersPeriod end
Profitability, sleeve percentile 81.9
Gross profitability5.8%[1-2,5]32.2%81.93722025-12-31
Return on invested capitalnot computable9.3%
one or more required annual facts are missing
Accruals rationot computable(6.6%)
a prior annual assets observation is required
Gross margin stability, five yearsnot computable2.8 pts
five annual gross margins are required; found 1
Solvency, sleeve percentile 72.7
Twelve-month failure probability0.05%0.07%32.82482026-06-30
Altman Z double-prime(81.59)[1,6-11](0.31)93.27562025-12-31
Net debt to EBITDAnot computable1.82x
one or more required annual facts are missing
Interest coveragenot computable(4.51x)
one or more required annual facts are missing
Current ratio0.73x[6-7]2.96x92.18392025-12-31
Growth and financing, sleeve percentile 88.6
Revenue growth, three-year compoundnot computable10.0%
four annual observations are required; found 1
Free cash flow growth, three-year compoundnot computable10.9%
four consecutive annual FCF observations are required; found 1
Reinvestment ratenot computable37.1%
a prior annual working-capital observation is required
Asset growth, three yearsnot computable2.1%
four annual observations are required; found 1
Net share issuance, one year169.6%[3-4]2.5%88.66342026-02-25

Gross profitability. Revenue less cost of goods sold, over total assets.

Accruals ratio. Net income less operating cash flow, over average assets; lower is stronger.

Gross margin stability, five years. Standard deviation of gross margin; lower is stronger.

Twelve-month failure probability. CHS model; lower is stronger.

Net debt to EBITDA. Lower is stronger.

Net share issuance, one year. Split-adjusted; lower is stronger.

Among 371 Peers [top]

What the Price Implies [top]

Market measures at the 2026-10-08 close. None enters the grade. Percentile among graded peers with the same measure.

MeasureValuePeer medianPercentileReading
Twelve-month price change, skipping the latest month91.3%8.0%86hotter than 86 of 100 peers
Distance from 52-week high(37.3%)(31.4%)40closer to its high than 40 of 100 peers
EBIT to enterprise value(23.7%)(1.5%)22pricier than 78 of 100 peers
Free cash flow yield(12.3%)(1.0%)30pricier than 70 of 100 peers
Book value to price0.390.2860pricier than 40 of 100 peers
Sales to price0.000.314pricier than 96 of 100 peers
Composite equity issuance, five yearsnot computable20.3%a share count from five years earlier is required
Relative strength against the sector, log excess return0.44(0.14)86ahead of 86 of 100 peers

Inputs: market equity $646.1M; EBIT -$93.9M; free cash flow -$79.8M; book equity $251.4M; sales $1.9M; debt $47,000; cash $249.9M[12].

Diagnostics [top]

Diagnostics do not feed the grade.

Piotroski F-score: None of 9, period end 2025-12-31
Return on assets above zeron/a
Operating cash flow above zero-$77.8M✗ fail[13]
Return on assets improvedn/a[14]
Operating cash flow exceeds net income$16.3M✓ pass[13-14]
Long-term leverage felln/a[1,15]
Current ratio improvedn/a[6-7]
No new shares issued169.6%✗ fail[3-4]
Gross margin improvedn/a[2,5]
Asset turnover improvedn/a[2]
Cash, filings, liquidity
Cash and equivalents$249.9M[16]
Operating cash flow, four quarters-$86.3M[13,16-20]
Months of runway34.8
Late filings, two years0
NT 10-K or NT 10-Q
Days since last periodic filing59
10-Q received Aug 11, 2026
Median daily dollar volume$6.6M
63 sessions
Days since newest grade input225

Downloads [top]

Sources [top]

Every citation on this page. Filing opens the SEC index page for that submission; viewer opens the SEC interactive data for the same filing; series opens the SEC XBRL API record for that tag and company.

#ConceptXBRL tagValuePeriod endReceivedFormLinks
1assetsus-gaap:Assets$23.0M2025-12-312026-02-2610-Kfiling · viewer · series
2revenueus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax$1.9M2025-12-312026-02-2610-Kfiling · viewer · series
3shares outstandingdei:EntityCommonStockSharesOutstanding97,232,0542026-02-252026-02-2610-Kfiling · viewer · series
4shares outstandingdei:EntityCommonStockSharesOutstanding36,062,3702025-04-282025-04-2910-K/Afiling · viewer · series
5cost of revenueus-gaap:CostOfGoodsAndServicesSold$569,0002025-12-312026-02-2610-Kfiling · viewer · series
6current assetsus-gaap:AssetsCurrent$15.7M2025-12-312026-02-2610-Kfiling · viewer · series
7current liabilitiesus-gaap:LiabilitiesCurrent$21.4M2025-12-312026-02-2610-Kfiling · viewer · series
8retained earningsus-gaap:RetainedEarningsAccumulatedDeficit-$370.5M2025-12-312026-02-2610-Kfiling · viewer · series
9operating incomeus-gaap:OperatingIncomeLoss-$93.9M2025-12-312026-02-2610-Kfiling · viewer · series
10book equityus-gaap:StockholdersEquity-$93,0002025-12-312026-02-2610-Kfiling · viewer · series
11liabilitiesus-gaap:Liabilities$23.2M2025-12-312026-02-2610-Kfiling · viewer · series
12shares outstandingdei:EntityCommonStockSharesOutstanding97,458,4742026-08-102026-08-1110-Qfiling · viewer · series
13operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$77.8M2025-12-312026-02-2610-Kfiling · viewer · series
14net incomeus-gaap:NetIncomeLoss-$94.1M2025-12-312026-02-2610-Kfiling · viewer · series
15long term debtus-gaap:LongTermDebtAndCapitalLeaseObligations$22,0002025-12-312026-02-2610-Kfiling · viewer · series
16cashus-gaap:CashAndCashEquivalentsAtCarryingValue$249.9M2026-06-302026-08-1110-Qfiling · viewer · series
17operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$49.5M2026-06-302026-08-1110-Qfiling · viewer · series
18operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$28.7M2026-03-312026-05-1210-Qfiling · viewer · series
19operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$59.3M2025-09-302025-11-1210-Qfiling · viewer · series
20operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$41.0M2025-06-302026-08-1110-Qfiling · viewer · series

Limitations [top]

Peer group. Sector assignment from four-digit SIC codes, hand-tuned and published. The grade under three alternative peer policies is tabled above.

Size. Within a sector the letter tracks size. Among graded filers in the smallest asset band, 72% grade E and 0% grade A; in the largest, 13% grade E and 21% grade A. Universe as of Oct 9, 2026.

Failure model. filings 2012-01-01 to 2019-12-31 fit, filings 2020-01-01 to 2025-12-31 test; status post hoc pending confirmation. pre-registered on 2026 filings once their 12-month outcome windows close; supported if the paired per-quintile gain over the pooled model has a lower bound above 0.05.

Input validity. Revenue or total assets at or below $100,000 sets the degenerate-inputs flag. An input whose denominator is at or below $100,000 is left not computable rather than ranked.

Returns. No input on this page has a post-2015 confidence interval on returns that excludes zero. The grade ranks reported financial condition and is not a return forecast.